Clinical Trials · NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Sun Yat-sen University
- Enrollment
- 55
- Start date
- May 2023
- Locations
- 2 sites, China
- Primary endpoint
- Objective Response Rate